Bionano Genomics, Inc.
BNGO
$4.14
$0.143.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.13M | -44.25M | -16.22M | -31.42M | -43.89M |
| Total Depreciation and Amortization | 2.45M | 5.68M | 3.04M | 3.06M | 3.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.91M | 24.06M | -3.43M | -5.07M | 16.72M |
| Change in Net Operating Assets | 2.27M | 1.20M | -4.36M | 5.30M | -6.25M |
| Cash from Operations | -6.50M | -13.31M | -20.98M | -28.13M | -29.78M |
| Capital Expenditure | 0.00 | 0.00 | -77.00K | -26.00K | -745.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00M | -5.38M | 28.71M | 47.61M | -54.63M |
| Cash from Investing | 3.00M | -5.38M | 28.63M | 47.59M | -55.37M |
| Total Debt Issued | 0.00 | 0.00 | 18.00M | -- | 80.00M |
| Total Debt Repaid | -2.01M | -3.02M | -24.35M | -36.68M | -9.01M |
| Issuance of Common Stock | 6.72M | 10.11M | 12.17M | 15.45M | 11.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -818.00K | -1.08M | -7.80M | -386.00K | -13.80M |
| Cash from Financing | 3.89M | 6.02M | -1.98M | -21.62M | 68.48M |
| Foreign Exchange rate Adjustments | -4.00K | 24.00K | -1.00K | -26.00K | 48.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 379.00K | -12.64M | 5.67M | -2.19M | -16.62M |